001     280894
005     20250905102148.0
024 7 _ |a 10.1177/22143602251325773
|2 doi
024 7 _ |a pmid:40396429
|2 pmid
024 7 _ |a 2214-3599
|2 ISSN
024 7 _ |a 2214-3602
|2 ISSN
037 _ _ |a DZNE-2025-00978
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Keipert, Lisa M
|b 0
245 _ _ |a Pain in adult and adolescent patients with 5q-associated Spinal Muscular Atrophy - an often underrated phenomenon.
260 _ _ |a Amsterdam
|c 2025
|b IOS Press
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1756281092_29816
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Spinal muscular atrophy (SMA) is a genetic disorder leading to progressive muscle weakness and atrophy. Pain in SMA may be the consequence of the underlying neuromuscular disease but has hardly been investigated so far.To assess pain in SMA and its interaction with patient's wellbeing.In a prospective, cross-sectional study design, 70 adult and adolescent SMA patients (median age 30 years, IQR 21-49 years, types I-IV) were assessed at the Department of Neurology, Ulm University hospital. Pain was evaluated with a self-adapted Pain Scale, depressiveness with the ALS-Depression-Inventory-12-Items (ADI-12) and global Quality of Life (gQoL) with the Anamnestic Comparative Self-Assessment (ACSA).We found an intermittent frequency of pain in 80% in SMA patients with more than half of the patients experience pain at least once a week. The mean pain intensity score estimated by pain frequency and strength was 24 on a scale of 0 to 240, indicating a frequently appearing mild to moderate pain. Pain was mostly located in the lumbar spine, hip, and thoracic spine. The pain intensity score was independent from demographics (age, gender) or clinical parameters (SMA type, physical state), but, instead, it was associated to depressiveness. Depressiveness was more prevalent in older SMA patients. gQoL was rather independent from pain intensity or physical state.The study provides evidence for a prevalence of mild to moderate pain in 80% of adult and adolescent SMA patients. Pain was not simply caused by physical deficits and did not severely interfere with patients' quality of life, but, instead, was closely interrelated with patients' affective state.
536 _ _ |a 353 - Clinical and Health Care Research (POF4-353)
|0 G:(DE-HGF)POF4-353
|c POF4-353
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
650 _ 7 |a SMA
|2 Other
650 _ 7 |a depression
|2 Other
650 _ 7 |a depressiveness
|2 Other
650 _ 7 |a pain
|2 Other
650 _ 7 |a quality of life
|2 Other
650 _ 7 |a spinal muscular atrophy
|2 Other
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Male
|2 MeSH
650 _ 2 |a Adult
|2 MeSH
650 _ 2 |a Female
|2 MeSH
650 _ 2 |a Cross-Sectional Studies
|2 MeSH
650 _ 2 |a Muscular Atrophy, Spinal: complications
|2 MeSH
650 _ 2 |a Muscular Atrophy, Spinal: genetics
|2 MeSH
650 _ 2 |a Muscular Atrophy, Spinal: psychology
|2 MeSH
650 _ 2 |a Adolescent
|2 MeSH
650 _ 2 |a Middle Aged
|2 MeSH
650 _ 2 |a Young Adult
|2 MeSH
650 _ 2 |a Quality of Life
|2 MeSH
650 _ 2 |a Prospective Studies
|2 MeSH
650 _ 2 |a Pain: etiology
|2 MeSH
650 _ 2 |a Pain: epidemiology
|2 MeSH
650 _ 2 |a Pain Measurement
|2 MeSH
650 _ 2 |a Depression
|2 MeSH
700 1 _ |a Wurster, Claudia
|0 P:(DE-2719)9002006
|b 1
700 1 _ |a Uzelac, Zeljko
|0 0000-0003-2479-2025
|b 2
700 1 _ |a Dorst, Johannes
|0 P:(DE-2719)9001951
|b 3
|u dzne
700 1 _ |a Schuster, Joachim
|0 P:(DE-2719)9002279
|b 4
|u dzne
700 1 _ |a Wollinsky, Kurt
|0 0009-0001-5436-8033
|b 5
700 1 _ |a Ludolph, Albert
|0 P:(DE-2719)2812633
|b 6
|u dzne
700 1 _ |a Lule, Dorothee
|0 P:(DE-2719)9002172
|b 7
|u dzne
773 _ _ |a 10.1177/22143602251325773
|g Vol. 12, no. 5, p. 662 - 669
|0 PERI:(DE-600)2802674-3
|n 5
|p 662 - 669
|t Journal of neuromuscular diseases
|v 12
|y 2025
|x 2214-3599
856 4 _ |u https://pub.dzne.de/record/280894/files/DZNE-2025-00978.pdf
|y OpenAccess
856 4 _ |u https://pub.dzne.de/record/280894/files/DZNE-2025-00978.pdf?subformat=pdfa
|x pdfa
|y OpenAccess
909 C O |o oai:pub.dzne.de:280894
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 3
|6 P:(DE-2719)9001951
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 4
|6 P:(DE-2719)9002279
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 6
|6 P:(DE-2719)2812633
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 7
|6 P:(DE-2719)9002172
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-353
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Clinical and Health Care Research
|x 0
914 1 _ |y 2025
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2025-01-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2025-01-02
915 _ _ |a Creative Commons Attribution CC BY 4.0
|0 LIC:(DE-HGF)CCBY4
|2 HGFVOC
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2025-01-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2025-01-02
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2025-01-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2025-01-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2025-01-02
920 1 _ |0 I:(DE-2719)5000077
|k Clinical Study Center (Ulm)
|l Clinical Study Center (Ulm)
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-2719)5000077
980 1 _ |a FullTexts


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21